Back to LOS ANGELES CAPITAL MANAGEMENT LLC LOS ANGELES CAPITAL MANAGEMENT LLC

SYRESYRE
4 quarters

Position history for LOS ANGELES CAPITAL MANAGEMENT LLCLOS ANGELES CAPITAL MANAGEMENT LLC's holdings in SPYRE THERAPEUTICS INC

LOS ANGELES CAPITAL MANAGEMENT LLC holds 2,310 shares of SYRE (SPYRE THERAPEUTICS INC), worth $205,082 as of 2026-Q2. The position was decreased (-60.6% shares). SYRE represents 0.0% of LOS ANGELES CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$205,082

Current Shares

2,310

Total Value Change

-$99,481

Total Shares Change

-15,862

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2,310
-60.6%
$205,0820.0%$88.78
0
2026-Q1
Decreased
5,858
-54.5%
$295,4770.0%$40.07
0
2025-Q4
Decreased
12,882
-29.1%
$312,5190.0%$31.88
0
2025-Q3
New
18,172
-
$304,5630.0%$16.36
32

Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used